Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Directorate Change

23 Nov 2023 10:00

RNS Number : 4621U
Phoenix Group Holdings PLC
23 November 2023

LEI: 2138001P49OLAEU33T68

23 November 2023

Phoenix Group Holdings plc - Board Changes

The Phoenix Group Holdings plc Board is pleased to announce that Eleanor Bucks will be appointed as an independent Non-Executive Director with effect from 1 December 2023.

Eleanor is currently Chief Investment Officer of Lloyd's of London where she has gained strong corporate governance experience as a member of the Lloyds Investment Committee, a Council of Lloyd's sub-committee, while responsible for the investment management of c.£14bn in assets globally, and investment oversight and leadership for the c.£95bn of assets within the Lloyd's market and capital setting for market risk.

She previously spent 15 years at Legal & General in increasingly senior and varied roles, whilst also developing her governance skillset as a member of the divisional Executive Committee, Investment Committee, Chair of the divisional Sustainability Committee, and Chair of the divisional Direct Investment Committee. In the context of life assurance, her experience includes investment management, risk management, customer solutions and operations. She is a proven leader who has a deep understanding of sustainable assets and ESG, and the development of alternative retirement products.

Commenting on the appointment, Alastair Barbour, Chair of Phoenix Group said:

"We are delighted that Eleanor has agreed to join the Board of Phoenix Group Holdings plc. She is an accomplished Actuary and Chief Investment Officer demonstrating strong financial services, insurance and stakeholder management experience. She brings fresh capability and skills together with a deep understanding of both our business and markets and will be a positive resource as Phoenix pursues its long-term strategy."

There is no further information required to be notified under Listing Rule 9.6.13 R with regard to Eleanor Bucks's appointment referred to above.

Enquiries:

Media Douglas Campbell

Teneo

+44 (0)7753 136628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031

Investors Claire Hawkins, Corporate Affairs Director, Phoenix Group +44 (0) 204 559 3161

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0) 204 559 3145

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAKZMZMRFFGFZG
Date   Source Headline
14th Mar 20259:00 amRNSBoard Change
6th Mar 20253:35 pmRNSDirector/PDMR Shareholding
3rd Mar 202511:12 amRNSTotal Voting Rights
6th Feb 20254:12 pmRNSDirector/PDMR Shareholding
5th Feb 20255:41 pmRNSCompletion of Early Redemption
3rd Feb 20255:47 pmRNSTotal Voting Rights
7th Jan 20252:19 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:00 amRNSTotal Voting Rights
2nd Jan 20258:30 amRNSAnnouncement of Early Redemption
12th Dec 20244:35 pmRNSBlock Listing Application
12th Dec 20244:11 pmRNSBlock listing Return
6th Dec 20245:39 pmRNSDirector/PDMR Shareholding
4th Dec 20249:00 amRNSDirectorate Change
2nd Dec 20241:32 pmRNSTotal Voting Rights
6th Nov 20245:48 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSDirectorate Change
5th Nov 20249:22 amRNSDirector/PDMR Shareholding
1st Nov 202412:48 pmRNSDirector/PDMR Shareholding
1st Nov 202412:43 pmRNSTotal Voting Rights
22nd Oct 20244:19 pmRNSDirector/PDMR Shareholding
8th Oct 20245:24 pmRNSDirector/PDMR Shareholding
4th Oct 20243:35 pmRNSDirector/PDMR Shareholding
1st Oct 202410:56 amRNSTotal Voting Rights
18th Sep 202410:56 amRNSDirector/PDMR Shareholding
17th Sep 202411:09 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNS2024 Interim Results
10th Sep 20243:54 pmRNSDirector/PDMR Shareholding
6th Sep 20248:58 amRNSMajor Shareholding
2nd Sep 202411:08 amRNSTotal Voting Rights
28th Aug 20249:16 amRNSDirectorate Change
6th Aug 20245:02 pmRNSDirector/PDMR Shareholding
1st Aug 20241:28 pmRNSTotal Voting Rights
8th Jul 20245:44 pmRNSDirector/PDMR Shareholding
1st Jul 20244:32 pmRNSTotal Voting Rights
26th Jun 20247:00 amRNSPhoenix Group to explore the sale of SunLife
20th Jun 20247:00 amRNSDeleveraging Programme Update
14th Jun 20248:14 amRNSResult of Tender Offer
11th Jun 20241:51 pmRNSBlock listing Return
10th Jun 20244:15 pmRNSPublication of Offering Memorandum
6th Jun 20245:14 pmRNSDirector/PDMR Shareholding
6th Jun 20242:11 pmRNSIssue of debt and tender maximum acceptance amount
5th Jun 20247:29 amRNSTender Offers and New Issue
3rd Jun 20241:27 pmRNSTotal Voting Rights
24th May 202411:05 amRNSDirector/PDMR Shareholding
14th May 20242:43 pmRNSResult of AGM
13th May 20247:00 amRNSDirectorate Change
8th May 20244:33 pmRNSDirector/PDMR Shareholding
3rd May 202411:04 amRNSAnnouncement of Early Redemption
1st May 202411:23 amRNSTotal Voting Rights
12th Apr 20244:41 pmRNSSupplemental Circular to the 2024 Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.